Feb. 12, 2004 — Zyomyx Inc. (News, Web), a Hayward, Calif.-based developer of biochips for protein analysis, announced it has raised $10 million in funding.
null
Credit Suisse First Boston Private Equity led the round. Existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners and Bio One Capital Pte Ltd. also participated.
null
The company’s president and chief executive, Bob Monaghan, said in a prepared statement that the investment will let the company expand the line of its biochip platform, which was introduced in 2003. Zyomyx expects to launch its next biochip in April, in addition to more chips later in the year.